GPER G-1 DEVELOPMENT GROUP
GPER G-1 Development Group develops a novel therapeutic for the treatment of diabetes and obesity. The company’s leading drug candidate for the treatment of obesity (through weight loss) and the treatment of diabetes and pre-diabetes (by restoring insulin sensitivity and glucose homeostasis) is Tespria, the GPER agonist G‑1.
GPER G-1 DEVELOPMENT GROUP
Industry:
Health Care Health Diagnostics Medical Therapeutics
Website Url:
http://www.gperg1.com
Status:
Active
Similar Organizations
3X Genetics
3X Genetics develops medical screening solutions to identify genetic disorders.
Endobetix
A Non-Surgical Solution to Treat Type 2 Diabetes and Obesity
Gismo Therapeutics
Gismo Therapeutics, a biotechnology startup, develops small-molecule therapeutics for the treatment of Alzheimer’s and Parkinson’s diseases.
I Heart Care
I Heart Care help keep track of health information both electronically and printed.
Innovative Healthcare
Innovative Healthcare develops therapeutics for the treatment of diabetes and chronic wounds.
POTS Treatment Center
The POTS Treatment Center offers patients collaborative, alternative care aimed at treating the whole person, not just the disorder.
Official Site Inspections
http://www.gperg1.com
- Host name: 130.0.153.160.host.secureserver.net
- IP address: 160.153.0.130
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "GPER G-1 Development Group"
GPER G-1 Development Group – A Novel Therapeutic for the …
Diabetes mellitus Diabetes mellitus is a group of metabolic diseases characterized by hyperglycemia due to deficiencies in insulin secretion and/or insulin action.See details»
News – GPER G-1 Development Group
Sep 25, 2020 The portfolio company GPER G-1 Development Group was launched by New Mexico Start-Up Factory (NMSUF), a New Mexico based organization that specializes in …See details»
GPER G-1 Development Group - Crunchbase Company …
GPER G-1 Development Group develops a novel therapeutic for the treatment of diabetes and obesity. The company’s leading drug candidate for the treatment …See details»
GPER G-1 Development Group LLC - VentureRadar
"GPER-G-1 is a drug development company with the primary goal of advancing novel drug candidates discovered at the University of New Mexico (UNM). Currently identified indications …See details»
GPER G-1 Development Group LLC Company Profile - Dun
Find company research, competitor information, contact details & financial data for GPER G-1 Development Group LLC of Albuquerque, NM. Get the latest business insights from Dun & …See details»
GPER G-1 Development Group receives STTR Grant for the …
The portfolio company GPER G-1 Development Group was launched by New Mexico Start-Up Factory (NMSUF), a New Mexico based organization that specializes in commercializing …See details»
GPER G-1 Development Group - LinkedIn
Diabetes is a growing concern globally—it is a leading cause of death and is projected to increase from 415 million diabetics in 2015 to approximately 642 million in 2040. GPER G-1 Development ...See details»
GPER G-1 Development Group LLC: Drug pipelines, Patents, …
Explore GPER G-1 Development Group LLC with its drug pipeline, therapeutic area, technology platform, 2 news.See details»
Science – GPER G-1 Development Group
Nov 12, 2019 Researchers at the University of New Mexico have recently characterized the novel G protein-coupled Estrogen Receptor (GPER) as a novel therapeutic target for obesity …See details»
UNM Startup GPER G-1 Development Group Receives STTR Grant
Jul 21, 2020 The portfolio company GPER G-1 Development Group was launched by New Mexico Start-Up Factory (NMSUF), a New Mexico based organization that specializes in …See details»
GPER G-1 Development Group LLC | www.inknowvation.com
Public Profile GPER-G-1 is a drug development company organized around advancing novel drug candidates discovered at the University of New Mexico (UNM). Currently identified indications …See details»
Treatment – GPER G-1 Development Group
GPER-1 Development Group LLC has licensed the promising technology from the University of New Mexico and New Mexico State University PRESS RELEASE: JULY 15, …See details»
GPER G-1 Development Group - ZoomInfo
View GPER G-1 Development Group (www.gperg1.com) location in New Mexico, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Gper G-1 Development Group - Company Contact Details
See company details and contact information for Gper G-1 Development Group as well as related information and industry data.See details»
Firm - SBIR
Development of an innovative diabetes therapeutic via GPER targeting Amount: $299,952 Topic: 400 PROJECT SUMMARY Diabetes mellitus is a group of metabolic disorders characterized …See details»
GPER G-1 Development Group LLC | VentureRadar
Linnaeus Therapeutics USA n/a Linnaeus Therapeutics, Inc. is a privately held biopharmaceutical company focused on the development and commercialization of novel, small molecule …See details»
GPER G-1 Development Group Overview - SignalHire
Diabetes is a growing concern globally—it is a leading cause of death and is projected to increase from 415 million diabetics in 2015 to approximately 642 million in 2040. GPER G-1 …See details»
GPER G-1 DEVELOPMENT GROUP ANNOUNCES: RESEARCHERS …
Feb 20, 2020 The portfolio company GPER G-1 Development Group was launched by New Mexico Start-Up Factory (NMSUF), a New Mexico based organization that specializes in …See details»
Get in Touch – GPER G-1 Development Group
Get in touch If you’d like more information about our company, please fill out the form below and a member of our team will get in touch with you.See details»
Chromatin loops are an ancestral hallmark of the animal regulatory ...
4 days ago The physical organization of the genome in non-bilaterian animals and their closest unicellular relatives is characterized; comparative analysis shows chromatin …See details»